Tag: Lou Ruvo Center for Brain Health

Poster-Disease-modifying Therapy

Characteristics and Outcomes By Employment and Education Status for Patients Treated with Peginterferon Beta-1a or Intramuscular Interferon Beta-1a

Background: Although socioeconomic disparities that lead to differences in multiple sclerosis (MS) outcomes have been identified, specific...

Read More

Platform-Disease Management

How the COVID-19 Pandemic Has Changed Multiple Sclerosis Clinical Practice: Results of a Nationwide Provider Survey

Background: The COVID-19 crisis has created unanticipated changes in health care delivery for people living with multiple sclerosis (MS)....

Read More